Contact Information

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

PediatricsInfectious Diseases700 Children’s DrColumbus, OH 43205 (map)

Learn more about Christopher P. Ouellette

Biography

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

Awards, Honors & Organizations

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

Research

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Contact Information

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

PediatricsInfectious Diseases700 Children’s DrColumbus, OH 43205 (map)

Learn more about Christopher P. Ouellette

Biography

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

Awards, Honors & Organizations

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

Research

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Contact Information

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

PediatricsInfectious Diseases700 Children’s DrColumbus, OH 43205 (map)

Learn more about Christopher P. Ouellette

Contact Information

  • Call us at:
  • (614) 722-4450
  • Fax us at:
  • (614) 722-4458
  • PediatricsInfectious Diseases700 Children’s DrColumbus, OH 43205 (map)

Learn more about Christopher P. Ouellette

Biography

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Biography

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Biography

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Chris Ouellette, MD, is a member of the Section of Infectious Diseases and Host Defense Program at Nationwide Children’s Hospital, and assistant professor of Pediatrics at The Ohio State University College of Medicine. His clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Patient Care

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

Locations

Main Campus of Nationwide Children’s Hospital

  • Main Campus of Nationwide Children’s Hospital

Academic and Clinical Areas

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

Academic and Clinical Areas

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

Academic and Clinical Areas

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

Infectious Diseases

Physician Team

Host Defense Fellowship

Faculty

Infectious Diseases Fellowship

Faculty

Host Defense Program

Physician Team

Primary Department

Pediatrics

Primary Section

Infectious Diseases

  • Infectious Diseases
  • Physician Team
  • Host Defense Fellowship
  • Faculty
  • Infectious Diseases Fellowship
  • Faculty
  • Host Defense Program
  • Physician Team
  • Primary Department
  • Pediatrics
  • Primary Section
  • Infectious Diseases

Awards, Honors & Organizations

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

Awards, Honors & Organizations

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

Awards, Honors & Organizations

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021 Member, American Society of Transplantation, 2019 - Present Fellow, American Academy of Pediatrics, 2013 - Present Member, Infectious Diseases Society of America, 2013 - Present Member, Pediatric Infectious Diseases Society, 2013 - Present

  • Hall Award - Clinically Innovative Research Award by a Junior Investigator, Pediatric Infectious Disease Society, 2021
  • Member, American Society of Transplantation, 2019 - Present
  • Fellow, American Academy of Pediatrics, 2013 - Present
  • Member, Infectious Diseases Society of America, 2013 - Present
  • Member, Pediatric Infectious Diseases Society, 2013 - Present

Research

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Research

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Research

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children. Publications

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

Dr. Ouellette’s clinical interests include infectious diseases in children, with an emphasis on the prevention, diagnosis, and treatment of infections in immunocompromised children. His primary research interests include novel therapeutic approaches, in particular adoptive immunotherapies for treatment of resistant or refractory viral infections in immunocompromised children.

                  Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14: 

                


                  Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;  

                


                  Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.

                


                  Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.

                


                  Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.

                


                  Auletta JJ, Sánchez PJ, Meyer EK, O'Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.

                


                  Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.

                


                  Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;  

View More Publications

  • Ouellette CP. Adoptive Immunotherapy for Prophylaxis and Treatment of Cytomegalovirus Infection. Viruses. 2022 Oct 27; 14:
  • Boutzoukas AE, Freedman DA, Koterba C, Hunt WG, Mack K, Cass J, Yildiz VO, de Los Reyes E, Twanow J, Chung MG, Ouellette CP. La Crosse Virus Neuroinvasive Disease in Children: A Contemporary Analysis of Clinical/Neurobehavioral Outcomes and Predictors of Disease Severity. Clin Infect Dis. 2022 May 24;
  • Boutzoukas AE, Kussman A, Bajwa RPS, Ouellette CP. Disseminated Toxoplasmosis in a Child Following Allogeneic Hematopoietic Cell Transplantation. J Pediatric Infect Dis Soc. 2021 May 28; 10: 698-701.
  • Ouellette CP, Sánchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, Shimamura M, Chaussabel D, Lee L, Owen KE, Shoup AG, Ramilo O, Mejias A. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020 Jul 15; 11: 3548.
  • Hecht SM, Ardura MI, Yildiz VO, Ouellette CP. Central Venous Catheter Management in High-risk Children With Bloodstream Infections. Pediatr Infect Dis J. 2020 Jan; 39: 17-22.
  • Auletta JJ, Sánchez PJ, Meyer EK, O’Donnell LC, Cassady KA, Ouellette CP, Hecht S, Diaz A, Pavlek LR, Salamon DP, Gallagher CL, Bradbury H, Welfley SL, Magers J, Armbruster DL, Lamb MG, Nakkula RJ, Bosse K, Lee DA. Adjuvant haploidentical virus-specific T lymphocytes for treatment of disseminated adenovirus infection in a premature infant. J Allergy Clin Immunol. 2019 Aug; 144: 594-597.e4.
  • Ronchi A, Ouellette CP, Mejías A, Salamon D, Leber A, Pugni L, Mosca F, Sánchez PJ. Detection of cytomegalovirus in saliva from infants undergoing sepsis evaluation in the neonatal intensive care unit: the VIRIoN-C study. J Perinat Med. 2018 Dec 19; 47: 90-98.
  • Ouellette CP, Stanek JR, Leber A, Ardura MI. Pediatric Histoplasmosis in an Area of Endemicity: A Contemporary Analysis. J Pediatric Infect Dis Soc. 2018 Aug 14;

Education

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Education

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

Date of Appointment at Nationwide Children’s Hospital: 11/30/2016

Board Certifications

Pediatric Infectious Diseases Pediatrics

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2017

Fellowship

Nationwide Children’s Hospital

Date Completed: 06/30/2016

Residency

Nationwide Children’s Hospital

Date Completed: 06/30/2013

Medical School

Ohio State University College of Medicine

Date Completed: 06/13/2010

  • Pediatric Infectious Diseases
  • Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-4450

Fax us at: (614) 722-4458

                    Infectious Diseases700 Children's DrColumbus, OH 43205 (map)
  • Call us at:
  • (614) 722-4450
  • Fax us at:
  • (614) 722-4458
  • Infectious Diseases700 Children’s DrColumbus, OH 43205 (map)